ResultsIQ

ResultsIQ › Latest results › Fine Organic Industries Limited

Fine Organic Industries Limited Q2 FY27 results deck summary

NSE: FINEORG · BSE: 541557

Results deck of 3 Nov 2026, summarised by AI from the filing.

The deck gives no forward revenue, margin or capex guidance; it reports only Q2 and H1 FY27 results and business developments.

Key takeaways

  1. No guidance The deck gives no forward revenue, margin or capex guidance; it reports only Q2 and H1 FY27 results and business developments.
  2. Acquisition The 80% acquisition of Oleofine Organics Sdn. Bhd. completed on September 9, 2026 for ₹80.17 cr, making OFM and FOIT subsidiaries.
  3. Demand Demand remained stable in H1 FY27 with improved revenue performance, and exports were ~58% of H1 FY27 revenue.
  4. Costs Raw material, utility and ocean freight costs all rose substantially in H1 FY27 versus H1 FY26, with freight still rising QoQ.

Original filing on BSE

Fine Organic Industries Limited Q2 FY27 results

As filed: Revenue ₹729 cr (+22% year on year), EBITDA ₹185 cr (+37% year on year), PAT ₹152 cr (+40% year on year), EBITDA margin 25.4% (+274 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹694 cr (+18% year on year), EBITDA ₹176 cr (+42% year on year), PAT ₹138 cr (+18% year on year), EBITDA margin 25.4% (+426 bps). Score 97 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 426 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −0.2% in 28 days (Nifty 500: −1.9%).
  • Q4 FY26: Revenue ₹625 cr (+3% year on year), EBITDA ₹130 cr (+8% year on year), PAT ₹117 cr (+21% year on year), EBITDA margin 20.8% (+99 bps). Score 65 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was well above it. EBITDA margin rose 99 bps year on year. Share price after the results: +12.8% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹555 cr (+8% year on year), EBITDA ₹94.4 cr (−5% year on year), PAT ₹73.9 cr (−11% year on year), EBITDA margin 17.0% (−229 bps). Score 48 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 229 bps year on year. Revenue fell 7% from last quarter. Share price after the results: −6.7% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹597 cr (0% year on year), EBITDA ₹135 cr (−10% year on year), PAT ₹109 cr (−7% year on year), EBITDA margin 22.6% (−255 bps). Score 43 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 255 bps year on year. Profit fell 7% from last quarter. Share price after the results: +1.7% in 28 days (Nifty 500: +1.3%).
  • Q1 FY26: Revenue ₹588 cr (+7% year on year), EBITDA ₹124 cr (−11% year on year), PAT ₹117 cr (+4% year on year), EBITDA margin 21.1% (−437 bps). Score 41 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin fell 437 bps year on year. Other income 25% of PBT. Revenue fell 3% from last quarter. Share price after the results: −0.3% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹607 cr (+11% year on year), EBITDA ₹120 cr (−17% year on year), PAT ₹97.0 cr (−16% year on year), EBITDA margin 19.8% (−656 bps). Score 51 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 656 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +17.8% in 29 days (Nifty 500: +6.1%).
  • Q3 FY25: Revenue ₹513 cr (+5% year on year), EBITDA ₹99.0 cr (−17% year on year), PAT ₹83.0 cr (−12% year on year), EBITDA margin 19.3% (−509 bps). Score 27 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 509 bps year on year. Other income 25% of PBT. Consolidated profit -12% but standalone +27%. Revenue fell 14% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Fine Organic Industries Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.